JAKARTA: PT Kalbe Farma, a leading Indonesian pharmaceutical group, has reported net sales of 6.015 trillion rupiah (RM1.74bil) in the first quarter of 2021, marking a year-on-year increase of 3.8% and failing to impress investors.
The group expressed optimism and projected an annual increase of 5% to 6% in both sales and net profit, resting its hopes, in large part, on business related to the Covid-19 pandemic.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
